Allogene Therapeutics ALLO Earnings Call Transcripts

NASDAQ ALLO
$0.90 -0.03 (-3.41%)
At close: Nov 11, 2026 · 4:00 PM EST
7 earnings calls on file for Allogene Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Allogene Therapeutics Q3 2026 Earnings Call

Nov 5, 2026 5,919 words · 26 min read
  • Christine CassianoChief Corporate Affairs and Brand Strategy Officer
  • Zachary RobertsPresident and Chief Executive Officer
  • Geoff ParkerChief Financial Officer
  • Annie YoshiyamaSVP of Finance, Corporate Controller, and Principal Accounting Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Allogene Therapeutics Earnings Call Transcripts

Calls7
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 7 Allogene Therapeutics transcripts Register to get access to Allogene Therapeutics’s earnings call transcripts.